127 related articles for article (PubMed ID: 8208675)
1. [Iatrogenic demineralizing osteopathies].
Audran M
Presse Med; 1994 Feb; 23(6):271-3. PubMed ID: 8208675
[TBL] [Abstract][Full Text] [Related]
2. [Osteoporosis in rheumatoid arthritis--significance of alfacalcidol in prevention and therapy].
Schacht E
Z Rheumatol; 2000; 59 Suppl 1():10-20. PubMed ID: 10769429
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
[TBL] [Abstract][Full Text] [Related]
4. [Cortisone-induced osteoporosis: from physiopathology to treatment].
Audran M; Basle MF
Rev Med Interne; 1991; 12(6):458-9, 461-4. PubMed ID: 1792440
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid-induced bone loss. Prevention and management.
Picado C; Luengo M
Drug Saf; 1996 Nov; 15(5):347-59. PubMed ID: 8941496
[TBL] [Abstract][Full Text] [Related]
6. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
Reginster JY; Lecart MP; Richy F
J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
[TBL] [Abstract][Full Text] [Related]
7. Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol.
Schacht E
Calcif Tissue Int; 1999 Oct; 65(4):317-27. PubMed ID: 10485985
[TBL] [Abstract][Full Text] [Related]
8. Secondary osteoporosis.
Gennari C; Martini G; Nuti R
Aging (Milano); 1998 Jun; 10(3):214-24. PubMed ID: 9801731
[TBL] [Abstract][Full Text] [Related]
9. Management of osteoporosis due to ovarian failure.
Eastell R
Med Pediatr Oncol; 2003 Sep; 41(3):222-7. PubMed ID: 12868123
[TBL] [Abstract][Full Text] [Related]
10. NSAIDs/corticosteroids--primum non nocere.
Dequeker J
Adv Exp Med Biol; 1999; 455():319-25. PubMed ID: 10599363
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis: new hope for the future.
Masi L; Bilezikian JP
Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroid osteoporosis: practical implications of recent trials.
Sambrook PN
J Bone Miner Res; 2000 Sep; 15(9):1645-9. PubMed ID: 10976984
[TBL] [Abstract][Full Text] [Related]
13. Review article: Osteoporosis and inflammatory bowel disease.
Bernstein CN; Leslie WD
Aliment Pharmacol Ther; 2004 May; 19(9):941-52. PubMed ID: 15113361
[TBL] [Abstract][Full Text] [Related]
14. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
[TBL] [Abstract][Full Text] [Related]
15. Iatrogenic factors in femoral neck fractures.
Muckle DS
Injury; 1976 Nov; 8(2):98-101. PubMed ID: 1002296
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Anabolic steroids in corticosteroid-induced osteoporosis.
Adami S; Rossini M
Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study.
Reid DM; Hughes RA; Laan RF; Sacco-Gibson NA; Wenderoth DH; Adami S; Eusebio RA; Devogelaer JP
J Bone Miner Res; 2000 Jun; 15(6):1006-13. PubMed ID: 10841169
[TBL] [Abstract][Full Text] [Related]
19. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
20. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
